MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202617091737 A) filed by Ix Biopharma Limited; and Ix Biopharma Ltd on July 29, 2026, for Compositions And Methods For Delivering Glp-1 Agonists (metabolix).
Inventors include Lim, Chin Beng Stephen; Cook, Iain Bruce; Lee, Yip Hang Eddy; and Krishnarajah, Janakan.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: A composition comprising a glucagon-like peptide 1 (GLP-1) agonist for sublingual or buccal administration, wherein the composition comprises one or more agents selected from the group consisting of; sodium glycodeoxycholate; sodium deoxycholate; carboxymethyl cellulose; sodium alginate; SNAC (salcaprozate sodium); a non-ionic ester alkoxylate (or alkanoic acid ester alkoxylate); and soy lecithin.
Disclaimer: Curated by HT Syndication.
